Works matching DE "GENZYME Corp."

Results: 85

Announcements.

Published in:: Oncology (08909091), 2007, v. 21, n. 11, p. 1322
Publication type:: Article

Alemtuzumab Appears Safe, Effective, Even in Poor-Prognosis Leukemia Patients.

Published in:: Oncology (08909091), 2006, v. 20, n. 10, p. 1132
Publication type:: Article

News Blast.

Published in:: Bio-IT World, 2006, v. 5, n. 2, p. 24
Publication type:: Article

Guerilla Informatics -- Genzyme Style.

Published in:

Bio-IT World, 2006, v. 5, n. 2, p. 12

By:

Russell, John

Publication type:

Article

Biotech Beckons in Bonny Scotland.

Published in:

Bio-IT World, 2005, v. 4, n. 10, p. 46

By:

Jack, Lorna

Publication type:

Article

RECOMBINATION.

Published in:: Bio-IT World, 2003, v. 2, n. 9, p. 22
Publication type:: Article

Legal and regulatory update.

Published in:: Journal of Commercial Biotechnology, 2003, v. 10, n. 1, p. 92, doi. 10.1057/palgrave.jcb.3040059
Publication type:: Article

Adopting Solutions to Orphan Drug Shortages.

Published in:

U.C. Davis Law Review, 2015, v. 48, n. 5, p. 2077

By:

Helen Liu

Publication type:

Article

Timeline of events: A brief history of what made news this year.

Published in:: Nature Medicine, 2011, v. 17, n. 12, p. 1543, doi. 10.1038/nm1211-1543
Publication type:: Article

March on, not in.

Published in:: 2011
Publication type:: Editorial

NIH faces marching orders on orphan drug shortage.

Published in:

Nature Medicine, 2011, v. 17, n. 5, p. 522, doi. 10.1038/nm0511-522b

By:

Dolgin, Elie

Publication type:

Article

Genzyme, though unique, could be a bellwether for US biotech.

Published in:

Nature Medicine, 2011, v. 17, n. 2, p. 145, doi. 10.1038/nm0211-145

By:

Dolgin, Elie

Publication type:

Article

Pharmaceutical; trademark; patents; news.

Published in:

Journal of Generic Medicines, 2011, v. 8, n. 2, p. 117, doi. 10.1177/1741134311413530

By:

Milchior, R;
Charbonnel, S;
Benattar, E

Publication type:

Article

Drug that boosts nerve signals offers hope for multiple sclerosis.

Published in:

Nature, 2015, v. 520, n. 7548, p. 417, doi. 10.1038/520417a

By:

Ledford, Heidi

Publication type:

Article

Banking on the future: Biobanking human blood and tissue advances cancer research.

Published in:

2014

By:

Printz, Carrie

Publication type:

Other

At last: Genzyme falls to sanofi aventis.

Published in:

Chemistry & Industry, 2011, n. 5, p. 5

By:

Dorey, Emma

Publication type:

Article

Genzyme faces $175m FDA fines.

Published in:

Chemistry & Industry, 2010, n. 9, p. 5

By:

Dorey, Emma

Publication type:

Article

News in brief.

Published in:: Chemistry & Industry, 2008, n. 23, p. 9
Publication type:: Article

Genzyme deal.

Published in:: Chemistry & Industry, 2008, n. 15, p. 5
Publication type:: Article

Business Digest.

Published in:

Chemistry & Industry, 2008, n. 2, p. 13

By:

Eisberg, Neil

Publication type:

Article

Business Digest.

Published in:

Chemistry & Industry, 2007, n. 21, p. 13

By:

Eisberg, Neil

Publication type:

Article

News briefs.

Published in:: Chemistry & Industry, 2007, n. 18, p. 6
Publication type:: Article

Business Digest.

Published in:: Chemistry & Industry, 2007, n. 5, p. 14
Publication type:: Article

Business Digest.

Published in:

Chemistry & Industry, 2006, n. 24, p. 14

By:

Eisberg, Neil

Publication type:

Article

Movers & Shakers.

Published in:: Chemistry & Industry, 2003, n. 6, p. 30
Publication type:: Article

Co-Defense and Attack on Clinical Trials.

Published in:

Applied Clinical Trials, 2005, v. 14, n. 11, p. 28

By:

O'Donnell, Peter

Publication type:

Article

Market watch: Upcoming market catalysts in Q4 2011.

Published in:

Nature Reviews Drug Discovery, 2011, v. 10, n. 10, p. 723, doi. 10.1038/nrd3564

By:

Tucker, John

Publication type:

Article

Regulatory Affairs.

Published in:: 2009
Publication type:: Interview

News in brief.

Published in:: Nature Reviews Drug Discovery, 2008, v. 7, n. 6, p. 466, doi. 10.1038/nrd2611
Publication type:: Article

Joanna F. Haas.

Published in:: 2005
Publication type:: Interview

Patent Watch.

Published in:: Nature Reviews Drug Discovery, 2003, v. 2, n. 9, p. 690, doi. 10.1038/nrd1188
Publication type:: Article

Genzyme-Sanofi buyout is second largest biotech deal ever.

Published in:

Nature Biotechnology, 2011, v. 29, n. 4, p. 293, doi. 10.1038/nbt0411-293

By:

Ratner, Mark

Publication type:

Article

Shire's replacement enzymes validate gene activation.

Published in:

Nature Biotechnology, 2010, v. 28, n. 11, p. 1139, doi. 10.1038/nbt1110-1139a

By:

Moran, Nuala

Publication type:

Article

When patients march in.

Published in:

Nature Biotechnology, 2010, v. 28, n. 11, p. 1145, doi. 10.1038/nbt1110-1145

By:

Hughes, Virginia

Publication type:

Article

Sanofi/Genzyme hostile.

Published in:

Nature Biotechnology, 2010, v. 28, n. 11, p. 1142, doi. 10.1038/nbt1110-1142a

By:

Ratner, Mark

Publication type:

Article

Genzyme resumes shipping as Sanofi-aventis hovers.

Published in:

Nature Biotechnology, 2010, v. 28, n. 10, p. 994, doi. 10.1038/nbt1010-994c

By:

Ratner, Mark

Publication type:

Article

The path less costly.

Published in:

2010

By:

Huggett, Brady

Publication type:

Opinion

Genzyme partners TJAB.

Published in:

Nature Biotechnology, 2010, v. 28, n. 7, p. 637, doi. 10.1038/nbt0710-637b

By:

Rohn, Jennifer

Publication type:

Article

FDA crackdown on Genzyme.

Published in:

Nature Biotechnology, 2010, v. 28, n. 5, p. 388, doi. 10.1038/nbt0510-388

By:

Carson, Keith L.

Publication type:

Article

As Genzyme flounders, competitors and activist investors swoop in.

Published in:

Nature Biotechnology, 2010, v. 28, n. 1, p. 3, doi. 10.1038/nbt0110-3

By:

Allison, Malorye

Publication type:

Article

A third quarter improvement for biotech hiring.

Published in:

Nature Biotechnology, 2009, v. 27, n. 11, p. 1056, doi. 10.1038/nbt1109-1056

By:

Francisco, Michael

Publication type:

Article

Genzyme backs Osiris, despite Prochymal flop.

Published in:

Nature Biotechnology, 2009, v. 27, n. 11, p. 966, doi. 10.1038/nbt1109-966

By:

Allison, Malorye

Publication type:

Article

Virus stalls Genzyme plant.

Published in:

Nature Biotechnology, 2009, v. 27, n. 8, p. 681, doi. 10.1038/nbt0809-681a

By:

Bethencourt, Victor

Publication type:

Article

Genzyme's Lumizyme clears bioequivalence hurdles.

Published in:

Nature Biotechnology, 2009, v. 27, n. 8, p. 685, doi. 10.1038/nbt0809-685a

By:

Ratner, Mark

Publication type:

Article

Genzyme takes Campath bet.

Published in:

Nature Biotechnology, 2009, v. 27, n. 6, p. 498, doi. 10.1038/nbt0609-498a

By:

Huggett, Brady

Publication type:

Article

Osiris seals billion-dollar deal with Genzyme for cell therapy.

Published in:

Nature Biotechnology, 2009, v. 27, n. 2, p. 106, doi. 10.1038/nbt0209-106

By:

Mack, George S.

Publication type:

Article

FDA balks at Myozyme scale-up.

Published in:

Nature Biotechnology, 2008, v. 26, n. 6, p. 592, doi. 10.1038/nbt0608-592

By:

Mack, George

Publication type:

Article

Genzyme and Isis strike megadeal.

Published in:

Nature Biotechnology, 2008, v. 26, n. 3, p. 251, doi. 10.1038/nbt0308-251

By:

Mack, George S.

Publication type:

Article

News in brief.

Published in:

Nature Biotechnology, 2008, v. 26, n. 2, p. 147, doi. 10.1038/nbt0208-147

By:

DeFrancesco, Laura;
Francisco, Michael;
Huggett, Brady;
Lorenzo, Aaron;
Melton, Lisa;
Moran, Nuala;
Shaffer, Catherine;
Siva, Nayanah

Publication type:

Article

Alfimeprase to succeed Genentech's alteplase?

Published in:

Nature Biotechnology, 2006, v. 24, n. 8, p. 875, doi. 10.1038/nbt0806-875

By:

Vastag, Brian

Publication type:

Article